Press release
Dementia with Lewy Bodies (DLB) Market is expected to reach 6.8 million by 2034
Dementia with Lewy Bodies
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72099
The complexity of DLB often leads to underdiagnosis or misdiagnosis, as symptoms overlap with Alzheimer's and Parkinson's disease dementia. However, improved awareness, better diagnostic tools, and patient advocacy have begun to change the outlook. With an aging global population and increased emphasis on early detection, the DLB patient pool is expected to expand significantly between 2024 and 2034, creating opportunities for healthcare providers, pharmaceutical companies, and digital health innovators.
Market Overview
• Patient Pool 2024: ~4.4 million (estimated globally)
• Forecasted Patient Pool 2034: ~6.8 million
• Growth Rate (2024-2034): CAGR of 4.3%
Key Highlights
• Increasing elderly population driving prevalence.
• Improved diagnostic methods (biomarkers, neuroimaging, AI tools).
• Growing awareness among healthcare professionals and caregivers.
• Expanding therapeutic and supportive care ecosystem.
Segmentation Analysis
By Product / Therapy
• Symptomatic pharmacological therapies
o Cholinesterase inhibitors (rivastigmine, donepezil)
o NMDA receptor antagonists (memantine)
o Parkinson's disease drugs (levodopa, dopamine agonists)
o Antipsychotics (limited use due to sensitivity in DLB patients)
• Pipeline and investigational therapies
o Alpha-synuclein-targeted therapies
o Neuroprotective and regenerative agents
o Immunotherapy approaches
• Supportive therapies
o Physiotherapy and occupational therapy
o Sleep and behavioral management interventions
o Digital health monitoring and caregiver support platforms
By Platform
• Hospital pharmacies
• Retail pharmacies
• Specialty dementia care centers
• Online pharmacies
By Technology
• Pharmacological therapy (oral and transdermal formulations)
• Digital cognitive monitoring tools
• AI-based diagnostic imaging
• Biomarker-based assays
By End Use
• Hospitals and neurology clinics
• Memory care and dementia centers
• Homecare supported by telemedicine platforms
By Application
• Early-stage DLB
• Moderate DLB
• Advanced DLB
Summary:
DLB management is currently dominated by symptomatic therapies, but pipeline research into alpha-synuclein-targeted treatments and AI-driven diagnostics is expected to transform care in the next decade.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72099/dementia-with-lewy-bodies-patient-pool-analysis-market
Regional Analysis
North America
• Largest share in 2024, with strong prevalence in the U.S. and Canada.
• High awareness and access to memory clinics.
• Active clinical trials for disease-modifying therapies.
Europe
• Significant adoption of diagnostic imaging and biomarker testing in Germany, France, and the UK.
• Strong dementia care frameworks supporting growth.
Asia-Pacific
• Fastest-growing region (CAGR ~5.6%), due to rising elderly population in Japan, China, and India.
• Expanding investment in memory care infrastructure.
• Increasing patient enrollment in global clinical trials.
Middle East & Africa
• Limited diagnosis and treatment access but improving through NGO and government-backed dementia programs.
• Awareness campaigns slowly gaining traction.
Latin America
• Brazil and Mexico showing growing prevalence with aging demographics.
• Gradual adoption of pharmacological therapies and caregiver support systems.
Summary:
While North America and Europe dominate today, Asia-Pacific will see the fastest growth, reflecting demographic shifts and healthcare investment.
Market Dynamics
Key Growth Drivers
• Expanding global elderly population.
• Improved diagnostic accuracy through biomarkers and AI tools.
• Increasing caregiver and patient advocacy awareness.
• Rising healthcare expenditure on dementia-related services.
Key Challenges
• Lack of curative therapies - current treatments are symptomatic.
• Misdiagnosis with Alzheimer's or Parkinson's dementia.
• Limited availability of dementia specialists in developing regions.
• High caregiving and healthcare costs.
Latest Trends
• Growth of biomarker-based diagnostic tests (CSF, PET, blood-based assays).
• Expansion of digital cognitive monitoring and tele-neurology.
• Research into alpha-synuclein immunotherapies.
• Development of integrated dementia care models involving caregivers, digital tools, and community programs.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72099
Competitor Analysis
Major Players
• Novartis AG (Exelon - rivastigmine)
• Eisai Co., Ltd. (Aricept - donepezil)
• Allergan/AbbVie Inc. (Namenda - memantine)
• UCB S.A. (neurology pipeline)
• Roche Holding AG (alpha-synuclein research programs)
• Biogen Inc. (neurodegenerative pipeline)
• Johnson & Johnson (CNS drug development)
• Pfizer Inc. (neurology portfolio)
• Merck & Co., Inc. (CNS research)
• Emerging biotech firms working on neuroprotective and alpha-synuclein-targeted therapies.
Summary:
The DLB market is dominated by symptomatic therapy providers today, but biotech innovators focusing on alpha-synuclein and neuroprotection are expected to reshape the competitive landscape.
Conclusion
The dementia with Lewy bodies (DLB) patient pool is projected to grow from 4.4 million in 2024 to 6.8 million by 2034, at a CAGR of 4.3%. As awareness improves and diagnostic technologies advance, more patients will be correctly identified, leading to expanded treatment and care opportunities.
Key Takeaways:
• North America and Europe lead today, while Asia-Pacific grows fastest.
• Current care is symptomatic, but alpha-synuclein-targeted therapies and digital diagnostics are the future.
• Challenges include misdiagnosis, lack of curative options, and caregiving burden.
• Competitive activity centers on neurodegenerative pharma leaders and rare-disease biotech innovators.
Looking ahead, the DLB market will evolve from limited symptomatic management to integrated care models combining pharmacology, digital health, and community-based dementia support, offering a more holistic approach for patients and families.
This report is also available in the following languages : Japanese (レビー小体型認知症患者プール分析、市場), Korean (루이소체 치매 환자 풀 분석, 시장), Chinese (路易体痴呆症患者群体分析、市场), French (Analyse du bassin de patients atteints de démence à corps de Lewy et du marché), German (Demenz mit Lewy-Körpern Patientenpoolanalyse, Markt), and Italian (Analisi del pool di pazienti affetti da demenza con corpi di Lewy, mercato), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72099/dementia-with-lewy-bodies-patient-pool-analysis-market#request-a-sample
Our More Reports:
Single Cell Analysis Market
https://exactitudeconsultancy.com/reports/73499/single-cell-analysis-market
Tangential Flow Filtration Market
https://exactitudeconsultancy.com/reports/73500/tangential-flow-filtration-market
Multiomics Market
https://exactitudeconsultancy.com/reports/73501/multiomics-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dementia with Lewy Bodies (DLB) Market is expected to reach 6.8 million by 2034 here
News-ID: 4189311 • Views: …
More Releases from Exactitude Consultancy
Vacuum Insulated Pipe Market Projected to Reach USD 2.36 Billion by 2034
Introduction: A Market Built on Cryogenic Efficiency and Innovation
The global Vacuum Insulated Pipe (VIP) market is witnessing a steady surge driven by the expanding cryogenic industry, increased liquefied natural gas (LNG) trade, and rising demand for efficient liquid gas transportation systems. These specialized double-wall pipes, engineered with high vacuum insulation between inner and outer layers, have become indispensable in industries handling cryogenic fluids such as liquid nitrogen, oxygen, argon, and…
Solar PV Mounting Systems Market is Expected to Reach USD 31.7 Billion by 2034
Introduction: Powering the Next Decade of Solar Expansion
The Solar PV Mounting Systems Market is emerging as a crucial pillar in the clean energy revolution, enabling efficient, cost-effective, and durable installations of photovoltaic (PV) modules across rooftops, open fields, and floating structures. As the world accelerates toward carbon neutrality, the demand for robust, modular, and adaptable mounting systems has intensified across residential, commercial, and utility-scale solar projects.
Download Full PDF Sample Copy…
Tall Oil Fatty Acid Market projected to reach USD 2.21 billion by 2034
Introduction: A Sustainable Feedstock Powering the Future of Bio-based Chemicals
The Tall Oil Fatty Acid (TOFA) Market is gaining strong traction as industries increasingly shift toward renewable, sustainable, and bio-based chemical alternatives. Derived as a byproduct from the kraft pulping process of pine wood, TOFA has become a vital raw material in the production of alkyd resins, dimer acids, lubricants, coatings, and adhesives. Its unique composition-rich in oleic and linoleic acids-makes…
Lithium-Ion Battery Recycling Market Projected to Reach USD 27.3 Billion by 2034
Introduction: Powering the Circular Energy Transition
As the world accelerates toward electrification and clean energy, the demand for lithium-ion batteries has skyrocketed-fueling everything from electric vehicles (EVs) to smartphones and grid storage systems. However, this exponential growth brings with it an urgent environmental challenge: how to sustainably manage end-of-life batteries.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/25354
The Lithium-Ion Battery Recycling Market has emerged as a cornerstone of the global…
More Releases for DLB
Lewy Body Dementia Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials E …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lewy Body Dementia pipeline constitutes key companies continuously working towards developing Lewy Body Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Lewy Body Dementia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a…
Lewy Body Dementia Market Set to Grow Substantially Through 2034, DelveInsight P …
DelveInsight's "Lewy Body Dementia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Lewy Body Dementia, historical and forecasted epidemiology as well as the Lewy Body Dementia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Lewy Body Dementia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Lewy Body Dementia Market…
Lewy Body Dementia Market to Show Remarkable Growth Trends from 2024 to 2034, De …
DelveInsight's "Lewy Body Dementia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Lewy Body Dementia, historical and forecasted epidemiology as well as the Lewy Body Dementia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Lewy Body Dementia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Lewy Body Dementia Market…
Lewy Body Dementia Pipeline 2025: FDA Approvals and Clinical Trials Landscape wi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lewy Body Dementia pipeline constitutes key companies continuously working towards developing Lewy Body Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Lewy Body Dementia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report…
Lewy Body Dementia Pipeline Assessment 2024: Therapies, Clinical Trials, Key Com …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lewy Body Dementia pipeline constitutes key companies continuously working towards developing Lewy Body Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Lewy Body Dementia Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a…
Lewy Body Dementia Pipeline and Clinical Trials Assessment 2024: FDA Approvals, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lewy Body Dementia pipeline constitutes key companies continuously working towards developing Lewy Body Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Lewy Body Dementia Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/lewy-body-dementia-lbd-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Lewy Body Dementia Market.
The Lewy Body…
